Courtagen has released EpiSeek, a targeted next-generation sequencing-based test for epilepsy. The test targets 327 genes that are associated with epilepsy and nonspecific seizure disorders. The test is run out of the company's CLIA certified laboratory on the Illumina MiSeq.
New Products: Courtagen's EpiSeek Test
Nov 02, 2012